Capping and adenosine metabolism. Genetic and pharmacologic studies

Area of Science:

• Immunology
• Cell Biology
• Biochemistry

Background:

• Membrane immunoglobulin (Ig) capping is a crucial process in B cell activation and signaling.
• Adenosine metabolism plays a vital role in cellular functions, including methylation processes.

Purpose of the Study:

• To investigate the effect of agents interfering with adenosine metabolism on immunoglobulin (Ig) capping in lymphocytes.
• To explore the role of methylation defects in the inhibition of Ig capping.

Main Methods:

• Treatment of murine and human B cells with inhibitors of adenosine deaminase (coformycin) and adenosylhomocysteine hydrolase (3-deazaadenosine).
• Assessment of Ig capping, Thy-1 antigen capping, and responses to antilymphocyte antibodies.
• Analysis of Ig capping in patients with hereditary adenosine deaminase deficiency and post-bone marrow transplantation patients.
• Evaluation of the effect of calcium ionophore on Ig capping in treated cells.

Main Results:

• Coformycin, homocysteine, and adenosine combinations impaired Ig capping in B cells.
• 3-deazaadenosine also inhibited Ig capping, suggesting a role for adenosylhomocysteine hydrolase.
• Inhibition of Ig capping was specific and did not affect Thy-1 antigen capping.
• Patients with adenosine deaminase deficiency showed impaired Ig capping, while successful bone marrow transplant recipients did not.
• Calcium ionophore-induced disruption of Ig caps was not inhibited by the tested agents.

Conclusions:

• Aberrant adenosine metabolism, likely through a methylation defect, inhibits Ig capping in lymphocytes.
• The observed impairment in Ig capping is linked to disruptions in methylation pathways essential for membrane reorganization.